The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Many expect a rebound in 2024, and stirrings in the public company space signal that may come to fruition. Case in point, VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHE), made its first acquisition in several years with the $85 million acquisition of Covenant Health and Community Services’ hospice operations and one assisted living facility location.
Read the full article: Publicly Traded Hospice Companies Poised for Deals //
Source: https://hospicenews.com/2024/05/24/publicly-traded-hospice-companies-poised-for-deals/